Short-term exposure to tumor necrosis factor-α does not affect insulin- stimulated glucose uptake in skeletal muscle

Diabetes

Volumn 47, Issue 5, 1998, Pages 721-726

  Nolte, Lorraine A ^a   Hansen, Polly A ^a   Chen, May M ^a   Schluter, Jane M ^a   Gulve, Eric A ^a   Holloszy, John O ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FIBROBLAST; GLUCOSE TRANSPORT; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SKELETAL MUSCLE; SOLEUS MUSCLE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; 3T3 CELLS; ANIMALS; GLUCOSE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MICE; MUSCLE, SKELETAL; PHOSPHORYLATION; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; STIMULATION, CHEMICAL; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE;

EID: 0031939164     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.5.721     Document Type: Article

References (38)

1. REFERENCES 1 Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB: The expression of tumor necrosis factor in human adipose tissue. J Clin Invest 95:2111-2119, 1995
2. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-α direct role in obesity-linked insulin resistance. Science 259:87-91, 1993
3. Hofmann C, Lorenz K, Braithwaite SS, Colca JR, Palazuk BJ, Hotamisligil GS, Spiegelman BM: Altered gene expression for tumor necrosis factor-α and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 134:264-270, 1994
4. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM: Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95:2409-2415, 1995
5. Defronzo RA, Gunnarsson R, Bjorkman O, Olsson M, Wahren H: Effects of insulin on peripheral and splanchnic glucose metabolism in noninsuline- dependent (type II) diabetes mellitus. J Clin Invest 76:149-155, 1985
6. Hotamisigil GS, Budavari A, Murray D, Spiegelman BM: Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes: central role of tumor necrosis factor-α J Clin Invest 94:1543-1549, 1994
7. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA: The expression of TNFα by human muscle. J Clin Invest 97:1111-1116, 1996
8. Hotamisigli GS, Murray DL, Choy LN, Spiegelman BM: TNF-α inhibits signaling from insulin receptor PNAS 91:4854-4858, 1994
9. Guo D, Donner DB: Tumor necrosis factor promotes phosphorylation and bind- ing of insuling receptor substrate 1 to phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. J Biol Chem 271:615-618, 1996
10. Hotamisigli GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α-and obesity-induced insulin resistance. Science 271:665-668, 1996
11. Stephens JM, Lee J, Pilch PF: Tomor necrosis factors-α-induced insulin resistance in 3T3-L1adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J Biol Clin 272:971-976, 1997
12. Stephens JM, Pekala PH: Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-α. J Biol Chem 266:21839-21845, 1991
13. Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A: Tumor necrosis factor α suppress insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 268:26055-26058, 1993
14. Kanety H, Feinstien R, Papa MZ, Hemi R, Karasik A: Tumor Necrosis factor α-induced phosphorylation of insulin recepto substate-1 (IRS-1). J Biol Chem 270:23780-23784, 1995
15. Kroder G, Bossenmair B, Kellerer M, Capp E, Stoyanov B, Muhlhofer A, Berti L, Horikoshi H, Ulrich A, Haring H: Tumor necrosis factor-α- and hyperglycemia-induced Insulin resistance. J Clin Invest 97:1471-1477, 1996
16. Begum N, Ragolia L: Effect of tumor necrosis factor-α on insulin action in cultured rat skeletal muscle cells. Endocrinology 137:2441-2446 1996
17. Nesher R, Karl IE, Kaiser KE, Kipnis DM: Epitrochlearis muscle. I. Mechanical performance, energetics, and fiber composition. Am J Physiol 239:E454-E460, 1980
18. Henriksen EJ, Holloszy JO: Effect of diffusion distance on measurement of rat skeletal muscle glucose transport in vitro. Acta Physiol Scand 143:381-386, 1991
19. Tanti J-F, Gremeaux T, Van Obberghen E, Le Marchand-Brustel Y: Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. J Biol Chem 269:6051-6057, 1994
20. Laemmli UK Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond) 227:680-685, 1970
21. Towbin H, Siachelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354, 1979
22. Motor I, Schwenger P, Li W, Schlessinger J, Vilcek J: Tumor necrosis factor-α induced activation and increased tyrosine phosphorylation of mitogen-activatod protein (MAP) kinase in human fibroblasts. J Biol Chem 268:18994-18999, 1993
23. Gulve EA, Cartee GD, Holloszy JO: Prolonged incubation of skeletal muscle in vitro: prevention of increases in glucose transport. Am J Physiol 261:C154-C160, 1991
24. Hansen PA, Gulve EA, Holloszy JO: Suitability of 2-deoxyglucose for in vitro measurement of glucose transport activity in skeletal muscle. J Appl Physiol 76:979-985, 1994
25. Covera S, Jaspers S, Pasceri M: Acute inhibition of insulin-stimulated glucose transport by the phosphatase inhibitor, okadaic acid. J Biol Chem 266:9271-9275, 1991
26. Cornelius P, Marlowe M, Lee MD, Pekala PH: The growth factor-like effects of tumor necrosis factor-α. J Biol Chem 265:20506-20516, 1990
27. Holloszy JO, Hansen PA, Regulation of glucose transport into skeletal muscle. In Revises of Physiology Biochemistry and Pharmacology. Blaustem MP, Grunicke H, Habermann E, Pette D, Schultz G, Schweiger M, Eds. Berlin, Springer-Verlag, 1996, p. 99-193
28. Lee MD, Zentella A, Pekala PH, Cerami A: Effect of endotoxin-induced monokines on glucose metabolism in the muscle cell line L6. Proc Natl Acad Sci USA 84:2590-2594, 1987
29. Cornelius P, Lee MD, Marlowe M, Pekala PH: Monokine regulation of glucose transporter mRNA in L6 myotubes. Biochem Biophys Res Commun 165:429-436, 1989
30. Ranganathan S, Davidson MB: Effect of tumor necrosis factor-α on basal and insulin-stimulated glucose transport in cultured muscle and fat cells, Metabolism 45:1089-1094, 1996
31. Szalkowski D, White-Carrington S, Berger J, Zhang B: Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-α on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells. Endocrinology 136:1474-1481, 1995
32. Pedersen O, Bak JF, Andersen PH, Lund S, Moller DE, Flier JS, Kahn BB: Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes 39:865-870, 1990
33. Garvey WT, Maianu L, Hancock JA, Golichowski AM, Baron A: Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM. Diabetes 41:465-475, 1992
34. Sarabia V, Lam L, Burdett E, Leiter LA, Klip A: Glucose transport in human skeletal muscle cells in culture: stimulation by insulin and metformin, J Clin Invest 90:1386-1395, 1992
35. Lang CH, Dobrescu C, Bagby GJ: Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 130:43-52, 1992
36. Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor R: Effects of an engineered human anti-TNF-α antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 45:881-885, 1996
37. Scheen AJ, Castillo MJ, Paquot N, Lefebvre PJ, Belgium L. Neutralization of TNF-α in obese insulin resistant human subjects: no effect on insulin sensitivity (Abstract). Diabetes 45 (Suppl. 2):286A, 1996
38. Ventre J, Doebber T, Wu M, MacNaul K, Stevens K, Pasparakis M, Kollias G, Moller DE: Targeted disruption of the tumor necrosis factor-α gene: metabolic consequences in obese and nonobese mice. Diabetes 46:1526-1531, 1997